<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04920591</url>
  </required_header>
  <id_info>
    <org_study_id>0098548</org_study_id>
    <nct_id>NCT04920591</nct_id>
  </id_info>
  <brief_title>Doll Therapy in Dementia</brief_title>
  <acronym>DESCRIBE</acronym>
  <official_title>Efficacy of Doll thErapy Compared With Standard Treatment in the Control of Behavioral and Psychologic Symptoms and CaRegIver Burden of dEmentia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Azienda Ospedaliera Città della Salute e della Scienza di Torino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Behavioral and psychologic symptoms in dementia (BPSD) are frequent and represent a burden&#xD;
      for patients and caregivers, the use of a first line non-pharmacologic approach is highly&#xD;
      recommended. DESCRIBE is a randomized controlled trial on the effect of doll therapy (DT) on&#xD;
      BPSD in different clinical settings.&#xD;
&#xD;
      The investigators will enroll fifty-two nursing homes residents and 52 acute in-patients with&#xD;
      dementia and BPSD. Subjects will be randomized to DT or standard treatment (ST), The&#xD;
      investigators will measured agitation, delirium and caregiver burden with standard clinical&#xD;
      scales at baseline and during treatment. Nursing home residents will be evaluated after 45&#xD;
      and 90 days of treatment, in-patients will be evaluated at baseline and at hospital&#xD;
      discharge. In acute in-patients, a follow-up of 4 weeks after hospital discharge will be&#xD;
      carried out in order to evaluate the effect of DT withdrawal.&#xD;
&#xD;
      Primary outcomes will be the reduction of BPSD and the reduction of professional caregiver&#xD;
      burden Secondary outcome will be the reduction of delirium and of effect of family caregiver&#xD;
      burden.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">January 31, 2020</completion_date>
  <primary_completion_date type="Actual">October 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of behavioral and psychologic symptoms in dementia measured by Neuropsychiatric Inventory (NPI) scale and by the A.Di.Co scale</measure>
    <time_frame>10-45-90 days</time_frame>
    <description>Change in NPI and A.Di.Co scales</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in professional caregivers burden measured by the Greutzner scale</measure>
    <time_frame>10-45-90 days</time_frame>
    <description>change in professional caregiver burden</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of delirium measured by the Confusion assessment Method (CAM) scale</measure>
    <time_frame>45 and 90 days</time_frame>
    <description>change in delirium incidence</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in caregiver burden measured by the caregiver Burden Inventory (CBI)</measure>
    <time_frame>28 days</time_frame>
    <description>Change in CBI</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">104</enrollment>
  <condition>Dementia</condition>
  <arm_group>
    <arm_group_label>doll therapy (DT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>doll therapy (emathy dolls)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard treatment (ST)</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>standard clinical practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>doll treatment</intervention_name>
    <description>The doll used in the study is the &quot;empathy doll&quot;; these dolls are designed to obtain an optimal interaction with patients and to arouse empathy.</description>
    <arm_group_label>doll therapy (DT)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age ≥65 years;&#xD;
&#xD;
          -  diagnosis of dementia moderate to severe Clinical Dementia Rating scale (CDR) ≥2;&#xD;
&#xD;
          -  presence of agitation and/or aggressiveness;&#xD;
&#xD;
          -  manual and visual abilities sufficient in order to interact with the doll.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age &lt;65 years;&#xD;
&#xD;
          -  refuse to participate;&#xD;
&#xD;
          -  mild forms of dementia (CDR&lt;2);&#xD;
&#xD;
          -  contraindication for DT as experience of mournful or traumatic events related to&#xD;
             parental experience;&#xD;
&#xD;
          -  life expectancy lower than 3 months;&#xD;
&#xD;
          -  negative interaction with the doll.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>città della salute e della Scienza</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 2, 2021</study_first_submitted>
  <study_first_submitted_qc>June 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 10, 2021</study_first_posted>
  <last_update_submitted>June 8, 2021</last_update_submitted>
  <last_update_submitted_qc>June 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>Patrizia D'Amelio</investigator_full_name>
    <investigator_title>associated professor</investigator_title>
  </responsible_party>
  <keyword>behavioral and psychologic symptoms in dementia; hospital; doll therapy; non-pharmacological approach; nursing homes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

